NextCell Pharma AB (STO:NXTCL)
Sweden · Delayed Price · Currency is SEK 1.450
-0.050 (-3.33%)
Feb 11, 2026, 2:51 PM CET
-59.50% (1Y)
| Market Cap | 167.09M -8.6% |
| Revenue (ttm) | 11.06M -1.9% |
| Net Income | -35.14M |
| EPS | -0.46 |
| Shares Out | 111.39M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 260,352 |
| Average Volume | 1,426,502 |
| Open | 1.572 |
| Previous Close | 1.500 |
| Day's Range | 1.450 - 1.572 |
| 52-Week Range | 0.630 - 3.840 |
| Beta | 0.70 |
| RSI | 62.25 |
| Earnings Date | Feb 2, 2026 |